Skip to content

Ketamine research published in 2024

Page 2 of 26: studies 21 to 40 of 518, newest first. Back to the ketamine overview

Studies

Editorial: Biological Therapies and Eating Disorders.

European Eating Disorders Review December 15, 2024 Hubertus Himmerich, Beate Herpertz-Dahlmann, Sabrina Mörkl 4 citations

Blood-based biomarkers and neuroimaging techniques have improved our understanding of the underlying biology of eating disorders (EDs) and have increased our diagnostic portfolio. This editorial accompanies an article collection on novel biological approaches to treat EDs. The collection covers intermittent theta burst stimulation, therapeutic drug monitoring, pharmacological treatments...

DOI: 10.1002/erv.3166 (opens in new tab) Full text (opens in new tab) Ketamine Anorexia nervosa Binge eating disorder Bulimia nervosa +6

Effects of Ketamine on Frontoparietal Interactions in a Rule-Based Antisaccade Task in Macaque Monkeys.

Journal of Neuroscience December 11, 2024 Liya Ma, Nupur Katyare, Kevin Johnston et al. 1 citation

Cognitive control is engaged by working memory processes and high-demand situations like antisaccade, where one must suppress a prepotent response. While it is known to be supported by the frontoparietal control network, how intra- and interareal dynamics contribute to cognitive control processes remains unclear. N-Methyl-d-aspartate glutamate receptors (NMDARs) play a key role in prefrontal...

DOI: 10.1523/JNEUROSCI.1018-23.2024 (opens in new tab) Full text (opens in new tab) Cognitive control Functional connectivity Lateral prefrontal cortex Local field potentials +6

Esketamine and neurocognitive disorders in adult surgical patients: a meta-analysis.

BMC Anesthesiology December 5, 2024 Xing Lin, Xin Liu, Huoming Huang et al. 15 citations

Prior meta-analyses have established the potential of intravenous ketamine in safeguarding against neurocognitive impairment, but the efficacy of intravenous esketamine for the prevention of perioperative neurocognitive disorders (PND) remains uncertain. The primary aim of this meta-analysis was to conduct a comprehensive evaluation of the effects of esketamine on PND in adult surgical patients...

DOI: 10.1186/s12871-024-02803-3 (opens in new tab) Full text (opens in new tab) Meta-analysis Perioperative neurocognitive disorders Postoperative delirium Esketamine/ketamine/nmda antagonist +1

Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review.

International Journal of Molecular Sciences December 5, 2024 Simone Pardossi, Andrea Fagiolini, Alessandro Cuomo 43 citations

Brain-derived neurotrophic factor (BDNF) is critical for neuroplasticity, synaptic transmission, and neuronal survival. Studies have implicated it in the pathophysiology of depression, as its expression is significantly reduced in brain areas such as the prefrontal cortex and hippocampus in patients with depression. Our narrative review focuses on the relationship between BDNF, ketamine, and...

Effect of esketamine on postoperative quality of recovery in patients undergoing arthroscopic rotator cuff repair: protocol for a prospective, randomized, double-blind study.

Trials December 4, 2024 Qirong Sun, Jiao Luo, Shijia Zhang et al. 1 citation

The utilization of shoulder arthroscopic surgery has progressively increased as a prevalent surgical approach for the treatment and repair of rotator cuff injury in clinical practice. However, early postoperative pain and neurological dysfunction remain significant factors that impact patients' postoperative recovery. Esketamine, an NMDA receptor antagonist, effectively reduces opioid...

DOI: 10.1186/s13063-024-08600-0 (opens in new tab) Full text (opens in new tab) Esketamine Controlled hypotension Early recovery quality Anesthesia anaesthesia +7

Effects of Ketamine vs. Midazolam in Adolescent Treatment Resistant Depression.

Pharmaceuticals December 4, 2024 Andrea Macejova, Veronika Kovacova, Ingrid Tonhajzerova et al. 7 citations

Background: Adolescent treatment resistant depression (TRD) is increasing in recent years. While ketamine showed rapid antidepressant effects in adult TRD studies, research on its effectiveness in adolescents is limited. Methods: This study examines the effects of intravenous ketamine vs. midazolam on depressive and anxiety symptomatology assessed by the Montgomery-Åsberg Depression Rating...

Efficacy of adding ketamine to levobupivacaine in paravertebral block on acute and chronic pain in thoracotomy: a randomized controlled double-blinded trial.

PAIN Reports December 1, 2024 Saad Ahmed Moharam, Amgad Elshikh, Mohamed Abdelbadie et al. 3 citations

The inappropriate management of pain after thoracotomy results in serious complications. Several adjuvants have been added to the thoracic paravertebral block (TPVB) to enhance its effects. This work aimed to evaluate the effect of adding ketamine to TPVB on thoracotomy-related acute and chronic pain. This randomized controlled double-blinded trial included 60 patients scheduled for open...

DOI: 10.1097/PR9.0000000000001206 (opens in new tab) Full text (opens in new tab) Levobupivacaine Paravertebral block Pain management pain Pain control +8

A brief review of complex regional pain syndrome and current management.

Annals of medicine December 1, 2024 Alaa Abd-Elsayed, Cain W Stark, Natasha Topoluk et al. 41 citations

Complex regional pain syndrome (CRPS) is a debilitating chronic pain condition that, although exceedingly rare, carries a significant burden for the affected patient population. The complex and ambiguous pathophysiology of this condition further complicates clinical management and therapeutic interventions. Furthermore, being a diagnosis of exclusion requires a diligent workup to ensure an...

Impact of Continuous Infusion Ketamine Compared to Continuous Infusion Benzodiazepines on Delirium in the Intensive Care Unit.

Journal of Intensive Care Medicine December 1, 2024 Nicholas J Vollmer, Erin D Wieruszewski, Andrea M Nei et al. 3 citations

Purpose: The purpose of this study was to evaluate rates of delirium or coma-free days between continuous infusion sedative-dose ketamine and continuous infusion benzodiazepines in critically ill patients. Materials and Methods: In this single-center, retrospective cohort adult patients were screened for inclusion if they received continuous infusions of either sedative-dose ketamine or...

Intravenous Ketamine for Cancer Pain: A Single-Center Retrospective Analysis Comparing Fixed-Rate Versus Weight-Based Dosing.

Journal of Pain & Palliative Care Pharmacotherapy December 1, 2024 Leslie Siegel, Kyle Quirk, Gary Houchard et al. 2 citations

Although weak evidence exists to support subanesthetic ketamine for cancer pain treatment, successful use may be hindered in the absence of standardized dosing guidance. We aimed to compare the success rates of intravenous ketamine fixed-rate versus weight-based dosing strategies for cancer pain treatment, and to assess patient characteristics that correlate with treatment success. We conducted...

DOI: 10.1080/15360288.2024.2374297 (opens in new tab) Full text (opens in new tab) Fixed-rate dose Weight-based dose Pain management Ketamine therapy +3

Genetic ablation of the isoform γ of PI3K decreases antidepressant efficacy of ketamine in male mice.

IBRO Neuroscience Reports December 1, 2024 Gabriela N Vaz, Flávia C Turcato, Isabel A V Lima et al.

About one-third of major depressive disorder (MDD) patients demonstrate unresponsiveness to classic antidepressants, and even the clinical efficacy of fast-acting drugs such as ketamine varies significantly among patients with treatment-resistant depression. Nevertheless, the lack of suitable animal models that mimic a possible ketamine-resistant phenotype challenges the understanding of...

The antipsychotic potential of Salix Mucronata on ketamine-induced rats.

IBRO Neuroscience Reports December 1, 2024 Ntombifuthi P Ngubane, Musa V Mabandla, Brenda Z De Gama 3 citations

Salix mucronata is one of the herbal plants offered by the traditional health practitioners in KwaZulu-Natal, South Africa for the treatment of schizophrenia. This study aimed to investigate the effects of repeated administration of ketamine on social interaction, novelty and motivation in adult, male Sprague Dawley rats. It also aimed to investigate the potential of risperidone and the herbal...

DOI: 10.1016/j.ibneur.2024.06.003 (opens in new tab) Full text (opens in new tab) Herbal medicine Mental disorders Risperidone Salix mucronata +4

Comparing the hemodynamic effects of ketamine versus fentanyl bolus in patients with septic shock: a randomized controlled trial.

Journal of Anesthesia December 1, 2024 Maha Mostafa, Ahmed Hasanin, Basant Reda et al. 5 citations

Ketamine and fentanyl are commonly used for sedation and induction of anesthesia in critically ill patients. This study aimed to compare the hemodynamic effects of ketamine versus fentanyl bolus in patients with septic shock. This randomized controlled trial included mechanically ventilated adults with septic shock receiving sedation. Patients were randomized to receive either 1 mg/kg ketamine...

Sleep alterations in treatment-resistant depression patients undergoing ketamine treatment.

Pharmacological Reports December 1, 2024 Aleksander Kwaśny, Wiesław Jerzy Cubała, Adam Włodarczyk et al. 2 citations

This study examines self-reported sleep alterations in treatment-resistant depression (TRD) inpatients following intravenous ketamine administration. This is a post-hoc analysis of a naturalistic observational study, which enrolled 28 inpatients with treatment-resistant major depressive disorder and analyzed self-reported sleep changes (items 1-4; 'insomnia', 'nighttime restlessness', 'early...

Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment-resistant depression: A double-blind, randomized, placebo-controlled trial.

Psychiatry and Clinical Neurosciences December 1, 2024 Yohei Ohtani, Hideaki Tani, Kie Nomoto-Takahashi et al. 13 citations

Although the antidepressant effect of ketamine on treatment-resistant depression (TRD) has been frequently reported in North American and European countries, evidence is scarce among the Asian population. We aimed to evaluate the efficacy and safety of intravenous ketamine in Japanese patients with TRD. In this double-blind randomized placebo-controlled trial, 34 Japanese patients with TRD were...

The quest for optimal ketamine dosing formula in treatment-resistant major depressive disorder.

Pharmacological Reports December 1, 2024 Julia Kwaśna, Wiesław Jerzy Cubała, Aleksander Kwaśny et al. 4 citations

Emerging evidence indicates that intravenous ketamine is effective in managing treatment-resistant unipolar and bipolar depression. Clinical studies highlight its favorable efficacy, safety, and tolerability profile within a dosage range of 0.5-1.0 mg/kg based on actual body weight. However, data on alternative dosage calculation methods, particularly in relation to body mass index (BMI) and...

Serotonergic transmission plays differentiated roles in the rapid and sustained antidepressant-like effects of ketamine.

British Journal of Pharmacology December 1, 2024 Yong-Yu Yin, Jiao-Zhao Yan, Qian-Qian Wei et al. 13 citations

The emerging antidepressant effects of ketamine have inspired tremendous interest in its underlying neurobiological mechanisms, although the involvement of 5-HT in the antidepressant effects of ketamine remains unclear. The chronic restraint stress procedure was performed to induce depression-like behaviours in mice. OFT, FST, TST, and NSFT tests were used to evaluate the antidepressant-like...

Multi-level therapeutic actions of cannabidiol in ketamine-induced schizophrenia psychopathology in male rats.

Neuropsychopharmacology December 1, 2024 Charalampos Brakatselos, Alexia Polissidis, George Ntoulas et al. 10 citations

Repeated administration of ketamine (KET) has been used to model schizophrenia-like symptomatology in rodents, but the psychotomimetic neurobiological and neuroanatomical underpinnings remain elusive. In parallel, the unmet need for a better treatment of schizophrenia requires the development of novel therapeutic strategies. Cannabidiol (CBD), a major non-addictive phytocannabinoid has been...

DOI: 10.1038/s41386-024-01977-1 (opens in new tab) Full text (opens in new tab) CBD Schizophrenia treatment Brain research Psychiatric medicine

Residual Depressive Symptoms in Treatment-Resistant Bipolar Depression Following Short-Term Ketamine Administration.

Drugs - real world outcomes December 1, 2024 Michał Pastuszak, Wiesław Jerzy Cubała, Aleksander Kwaśny 3 citations

Residual symptoms are frequently observed in a significant number of patients with depression, indicating an unmet need for effective management strategies to achieve functional recovery. This observational study aimed to evaluate the impact of ketamine infusions on depressive symptoms in patients with bipolar disorder who continued their baseline psychotropic and chronic somatic treatments....

DOI: 10.1007/s40801-024-00453-y (opens in new tab) Full text (opens in new tab) Ketamine therapy Bipolar depression Treatment resistance Psychiatric medicine +1

Abnormal resting-state functional connectivity of the right anterior cingulate cortex in chronic ketamine users and its correlation with cognitive impairments.

Asian Journal of Psychiatry December 1, 2024 Jun Zhong, Fengchun Wu, Huawang Wu et al. 1 citation

Chronic ketamine use leads to cognitive impairments, however, the neural mechanisms underpinning these impairments are still unclear. Many studies showed Anterior cingulate cortex (ACC)is strongly involved in cognition and drug addiction, as supported by our previous studies. The objective of this study was to assess the variations in resting-state functional connectivity (FC) changes in the...

DOI: 10.1016/j.ajp.2024.104199 (opens in new tab) Full text (opens in new tab) Chronic ketamine use Cognitive impairments Functional connectivity Brain connectivity +3